United States · FDA National Drug Code directory

CEFTAZIDIME

Source ingredient · 11 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 0456-2700_b64cc1d6-6d52-4615-82b2-6dcaa9d9fefe

AVYCAZ

POWDER, FOR SOLUTION / Allergan, Inc.

United States · Source reference 25021-127_57ce314f-eda1-4438-8a50-2010d4d8aefd

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / Sagent Pharmaceuticals

United States · Source reference 25021-128_57ce314f-eda1-4438-8a50-2010d4d8aefd

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / Sagent Pharmaceuticals

United States · Source reference 25021-129_c6b97c07-4742-4c33-8266-a154bd634da5

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / Sagent Pharmaceuticals

United States · Source reference 44567-235_c1a9149a-efde-4f1c-a5f9-72a369d72c0e

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / WG Critical Care, LLC

United States · Source reference 44567-236_c1a9149a-efde-4f1c-a5f9-72a369d72c0e

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / WG Critical Care, LLC

United States · Source reference 44567-237_5b364685-59de-456c-96d0-fb2d99702c7e

Ceftazidime

INJECTION, POWDER, FOR SOLUTION / WG Critical Care, LLC

United States · Source reference 0409-5082_ab9c6f3a-f684-4cc3-b870-1a06a748a1a2

TAZICEF

INJECTION, POWDER, FOR SOLUTION / Hospira, Inc.

United States · Source reference 0409-5084_ab9c6f3a-f684-4cc3-b870-1a06a748a1a2

TAZICEF

INJECTION, POWDER, FOR SOLUTION / Hospira, Inc.

United States · Source reference 0409-5086_b4cff5d5-d1ec-4959-b062-e754517aab2d

TAZICEF

INJECTION, POWDER, FOR SOLUTION / Hospira, Inc.

United States · Source reference 0409-5093_71a753fc-ae3d-4d94-bc72-a3a51a5bdd9a

TAZICEF

INJECTION, POWDER, FOR SOLUTION / Hospira, Inc.

Browse ingredients in United States →